Pulrodemstat
Pulrodemstat (CC-90011) is a potent, selective, reversible and orally active inhibitor of lysine specific demethylase-1 (LSD1) with an IC50 of 0.25 nM. Pulrodemstat is less enzymatic inhibition against LSD2, MOA-A, and MAO-B. Pulrodemstat induces acute myeloid leukemia (AML) and small cell lung cancer (SCLC) cells differentiation and has potent anticancer activity[1].
Product Specifications
CAS Number
1821307-10-1
Product Name Alternative
CC-90011; LSD1-IN-7
UNSPSC
12352005
Target
Histone Demethylase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pulrodemstat.html
Solubility
10 mM in DMSO
Smiles
N#CC1=CC=C(C(N=C(N2CCC(N)CC2)N3C)=C(C4=CC=C(OC)C(F)=C4)C3=O)C=C1F
Molecular Formula
C24H23F2N5O2
Molecular Weight
451.47
References & Citations
[1]Toufike Kanouni, et al. Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1) . J Med Chem. 2020 Dec 10;63 (23) :14522-14529.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
KDM1/LSD1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EK341042 96 Well
Human EAR1 (Eosinophil Associated Ribonuclease A family Member 1) ValidElisa Kit
Sign In for Pricing
View Details 
C2087-29K-FITC 100 µL
Caspase 7, CT (Caspase-7, CASP 7, CASP7, CASP-7, Apoptosis-related Cysteine Peptidase, Apoptosis Related Cysteine Protease, Apoptotic Protease MCH3, CMH 1, CMH-1, ICE-like Apoptotic Protease 3, ICE LAP3, ICE-LAP3, MCH3) (FITC)
Sign In for Pricing
View Details